Pulmonary hypertension: types and treatments.

Area of Science:

• Cardiology
• Pulmonology
• Vascular Biology

Background:

• Pulmonary arterial hypertension (PAH) is a progressive disease affecting small pulmonary arteries, causing restricted blood flow.
• Increased afterload on the right ventricle leads to adaptive changes and eventual failure.
• Pulmonary hypertension can also arise from left heart disease, mimicking PAH symptoms.

Purpose of the Study:

• To highlight the importance of early diagnosis and treatment of Pulmonary Arterial Hypertension (PAH).
• To emphasize the need for accurate etiological categorization of pulmonary hypertension (PH) for effective treatment.

Main Methods:

• Review of current understanding of PAH pathophysiology.
• Analysis of clinical presentation and diagnostic challenges.
• Evaluation of available evidence-based treatment options.

Main Results:

• PAH causes significant pulmonary artery restriction and right ventricular strain.
• Vague early symptoms like dyspnea and exercise intolerance can delay diagnosis.
• Pulmonary vasodilators are effective treatments for PAH when employed early.

Conclusions:

• Accurate etiological classification of PH is essential for appropriate and safe treatment.
• Timely intervention with pulmonary vasodilators can improve outcomes for PAH patients.
• Failure to differentiate PH etiologies can lead to detrimental treatment decisions.